Medication info
Rivapita Tablet 2 mg (Pitavastatin Calcium Hydrate)

Rivapita Tablet 2 mg (Pitavastatin Calcium Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium Hydrate›2mg / 1 tablet
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
Very light yellowish-red round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202000700 · Approved 2020.02.06 · Insurance code 694002850

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 mg of pitavastatin calcium per dose, taken once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 mg per day. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response. The therapeutic effect of this medicine is maintained with continued administration.

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Hypercholesterolemia
  • dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated Apo-B protein
  • elevated triglyceride levels
View approved original text

This medication is used for the treatment of primary hypercholesterolemia and mixed dyslipidemia. It effectively lowers elevated levels of total cholesterol, LDL cholesterol, Apo-B protein, and triglycerides in the blood, helping to reduce the risk of cardiovascular diseases. It also increases HDL cholesterol levels, reinforcing the role of good cholesterol. As an adjunct to dietary therapy, it plays an important role in improving patients' blood lipid status, thereby helping to balance overall blood lipid levels and enhance health.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 mg of pitavastatin calcium per dose, taken once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 mg per day. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response. The therapeutic effect of this medicine is maintained with continued administration.

Precautions

This drug should not be used in patients with allergies to certain ingredients. Patients with impaired liver function or liver disease should avoid this medication. Patients with severe liver dysfunction or bile duct obstruction, as well as those with cholestasis, should also avoid this medication. Patients on cyclosporine should not take this drug concurrently. Patients with myopathy should not use this medication. Pregnant or potentially pregnant women and nursing mothers should not take this medication. The safety and efficacy of this medication have not been established in children, thus it is not used in pediatric populations. Patients with lactose intolerance or certain genetic conditions should also avoid taking this medication. Patients with renal impairment or those taking fibrates, niacin, etc. should use this drug with caution. Patients with impaired liver function or those consuming excessive alcohol need to exercise caution as well. Elderly patients or those with hypothyroidism or genetic muscle diseases should also be careful when using this medication. While taking this medication, symptoms such as myalgia, fatigue, liver function abnormalities, skin rashes, and thrombocytopenia may occur, so if any symptoms appear, consult a doctor immediately. Rhabdomyolysis, a serious muscle damage condition, may occur, so if severe muscle pain or weakness occurs, discontinue the medication immediately. This medication is mainly metabolized in the liver, so regular liver function tests should be performed, and if any abnormalities arise, the medication should be discontinued. When taking with other specific medications, there may be an increased risk of renal function deterioration or muscle-related side effects, so it is essential to consult a doctor. It is particularly advisable to avoid co-administration with cyclosporine, fibrates, niacin, erythromycin, etc. Elderly patients may experience side effects more easily due to decreased physical function, hence dose adjustment and caution are necessary. Pregnant or nursing women should not take this medication as it may harm the fetus or infant. The safety of this medication in children has not been established, so it is not used.

Side effects

  • Abdominal pain
  • rash
  • fatigue
  • paralysis
  • itching
  • myalgia
  • weakness
  • increased CPK levels
  • elevated myoglobin in blood and urine
  • acute renal failure
Show 84 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • urticaria
  • erythema
  • angioedema
  • increased bilirubin
  • elevated cholinesterase
  • increased AST
  • increased ALT
  • elevated γ-GT
  • increased ALP
  • elevated LDH
  • rigidity
  • drowsiness
  • insomnia
  • headache
  • heaviness of the head
  • dizziness
  • thirst
  • indigestion
  • abdominal distension
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • gastric discomfort
  • diarrhea
  • granulocytopenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • increased globulin
  • positive Coombs test
  • anemia
  • urine frequency
  • increased BUN
  • increased serum creatinine
  • decreased aldosterone
  • increased aldosterone
  • elevated adrenocorticotropic hormone
  • increased cortisol
  • decreased testosterone
  • muscle cramps
  • weakness
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing impairment
  • hematuria
  • increased uric acid levels
  • elevated serum potassium and phosphorus
  • dysgeusia
  • positive antinuclear antibodies
  • sleep disturbances
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • immune-mediated necrotizing myopathy
  • facial edema
  • arm swelling
  • hypersensitivity
  • headache
  • dizziness
  • skin tingling
  • insomnia
  • sleep disturbances
  • loss of appetite
  • increased blood pressure
  • feeling of chest discomfort
  • weakness
  • nausea
  • thrombocytopenia
  • increased serum creatinine
  • increased BUN

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a container that prevents light exposure. Additionally, it is recommended to store the medication at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and safety.

Appearance and packaging

Appearance

Very light yellowish-red round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.